Analyst Ranking
Bottom 3%
#4752 out of 4873 analysts
Average Return
-12.27%
Win Rate
28%10 out of 36
Risk vs Reward
Poor
Good

Thomas Flaten's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Diamedica Therapeutics IncDMAC
+220.63%$1.26$4.04
2022-07-06 -
2023-07-06
Strong Buy
Personalis IncPSNL
+158.50%$1.47$3.80
2024-04-29 -
2025-04-29
Strong Buy
Biolife Solutions IncBLFS
+152.95%$15.77$39.89
2020-02-23 -
2021-02-24
Strong Buy
Castle Biosciences IncCSTL
+101.72%$11.66$23.52
2023-06-04 -
2024-06-04
Strong Buy
Biolife Solutions IncBLFS
+73.46%$13.11$22.74
2023-08-08 -
2024-08-08
Strong Buy

Thomas Flaten Analyst Color

Get additional color on Thomas Flaten's coverage of popular stocks

Thomas Flaten's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Castle Biosciences IncCSTL
6Strong Buy$35.00+103.37%Maintains
2 days ago
Oncocyte CorpOCX
4Strong Buy$5.00+76.06%Initiates Coverage On
a month ago
Optinose IncOPTN
4Hold$9.00-4.15%Downgrades
2 months ago
Checkpoint Therapeutics IncCKPT
5Hold$4.10-0.97%Downgrades
2 months ago
Aquestive Therapeutics IncAQST
2Strong Buy$8.00+189.86%Maintains
2 months ago
Evaxion Biotech AEVAX
2Strong Buy$6.00+313.79%Maintains
3 months ago
Personalis IncPSNL
2Strong Buy$9.00+74.42%Maintains
4 months ago
Journey Medical CorpDERM
1Strong Buy$9.00+30.81%Initiates Coverage On
8 months ago
Dermtech IncDMTKQ
1Hold$0.63N/ADowngrades
a year ago
Assertio Holdings IncASRT
3Strong Buy$3.00N/AMaintains
a year ago
Achieve Life Sciences IncACHV
3Strong Buy$11.00N/AMaintains
a year ago
Better Therapeutics IncBTTX
2Strong Buy$3.00N/AMaintains
2 years ago
Biolife Solutions IncBLFS
2Strong Buy$25.00N/AMaintains
2 years ago
Diamedica Therapeutics IncDMAC
1Strong Buy$8.00N/AMaintains
3 years ago
Fresh Tracks Therapeutics IncFRTX
2HoldN/AN/ADowngrades
3 years ago
Ensysce Biosciences IncENSC
1Strong Buy$14,400.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.